Janssen Sciences Ireland UC

Lobbying Organisation Janssen Sciences Ireland UC

Date published 21 May, 2025

Relevant Matter Public policy or programme

Public Policy Area Economic Development and Industry

Period 1 Jan, 2025 to 30 Apr, 2025

Specific Details Interaction with Secretary General of the Department of Health

Intended results To adopt a holistic national strategy for the life sciences sector which aims for both public health and economic benefits. To protect the existing IP baselines and incentives framework in the context of the revision of the EU pharmaceutical legislation. To improve speed of patient access to new medicines in Ireland.

Name of person primarily responsible for lobbying on this activity Fergus Sharpe

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Informal communication (1)

Conversation at ESRI event in Dublin

Email (1)

Email to Secretary General of the Department of Health on the abovementioned topics.

Submission (2-5)

Sharing of EFPIA report on the Pharmaceutical Industry in Europe 2024 and accompanying Infographic on IP incentives.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Robert Watt Secretary General (Department of Health)